Biogen Inc. (LON:0R1B)
London · Delayed Price · Currency is GBP · Price in USD 141.67
-0.22 (-0.15%)
At close: Sep 8, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Multiple Sclerosis | 4.35B | Log In | Log In | Log In | Log In | Upgrade |
Multiple Sclerosis Growth | -8.10% | Log In | Log In | Log In | Log In | Upgrade |
Other | 2.46B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 18.44% | Log In | Log In | Log In | Log In | Upgrade |
Rare Disease | 1.99B | Log In | Log In | Log In | Log In | Upgrade |
Rare Disease Growth | 13.66% | Log In | Log In | Log In | Log In | Upgrade |
Biosimilars | 793.10M | Log In | Log In | Log In | Log In | Upgrade |
Biosimilars Growth | -2.17% | Log In | Log In | Log In | Log In | Upgrade |
Alzheimer's Disease | - | Log In | Log In | Log In | Log In | Upgrade |
Other Product | 82.50M | Log In | Log In | Log In | Log In | Upgrade |
Other Product Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 2.46B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 18.44% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | 2.46B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 15.14% | Log In | Log In | Log In | Log In | Upgrade |
United States | 3.24B | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | 3.33% | Log In | Log In | Log In | Log In | Upgrade |
International | 3.98B | Log In | Log In | Log In | Log In | Upgrade |
International Growth | -3.72% | Log In | Log In | Log In | Log In | Upgrade |
Other | 2.46B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 15.14% | Log In | Log In | Log In | Log In | Upgrade |